New BA.3.2 Covid Variant Detected Across Multiple US States
A newly identified Covid variant, designated BA.3.2, is spreading across the United States and shows potential to evade immunity conferred by current vaccines. Researchers from the Centers for Disease Control and Prevention (CDC) have reported the variant's presence in nasal swabs from four American travelers and clinical samples from five patients across four unidentified states.
Widespread Detection Through Wastewater Surveillance
The variant's reach appears significantly more extensive than initial clinical findings suggest. BA.3.2 has been identified in three airplane wastewater samples and 132 wastewater samples collected from more than 20 states, indicating broader community transmission than currently documented through testing.
First detected in South Africa in 2024, the variant entered the United States in June 2025 via a traveler from the Netherlands. Following a notable surge beginning in September 2025, BA.3.2 has now been reported in 23 countries worldwide.
Genetic Distinctiveness and Vaccine Implications
In their Morbidity and Mortality Weekly Report, CDC researchers emphasized that BA.3.2 is "genetically distinct from the JN.1 lineages that have circulated in the United States since January 2024." This distinction raises concerns about the effectiveness of current vaccines, which specifically target JN.1 subvariants.
The variant carries approximately 70 to 75 genetic mutations in its spike protein—the component enabling coronavirus entry into human cells. These alterations potentially enhance both transmissibility and immune evasion capabilities.
Laboratory Studies Reveal Reduced Vaccine Effectiveness
Laboratory investigations demonstrated that BA.3.2 evades protective antibodies generated by Covid vaccines, "likely because of spike protein mutations." Researchers noted that the 2025–2026 LP.8.1-adapted mRNA Covid-19 vaccine, while protective against predominant JN.1 strains, showed the lowest antibody neutralization against BA.3.2 among seven variants tested.
Geographic Spread and Clinical Observations
BA.3.2 has been confirmed in:
- California, Connecticut, Florida, Hawaii, Idaho, Illinois
- Maine, Maryland, Massachusetts, Missouri, New Hampshire
- New Jersey, Nevada, New York, Pennsylvania, Rhode Island
- South Carolina, Texas, Utah, Vermont, Virginia
- Wyoming, Louisiana, Michigan, and Ohio
Despite this widespread detection, BA.3.2 does not currently dominate US Covid variants. Reported cases have not demonstrated increased severity compared to other infections. The variant was identified in hospitalized patients during December and January in three unidentified states, including two older adults with comorbidities and one young child receiving outpatient care. All patients survived, and researchers cautioned that hospitalization detection "does not necessarily indicate that the variant causes more severe disease."
Endemic Context and Evolutionary Concerns
With Covid now considered endemic, viral mutation continues as expected. Virologist Angela Rasmussen of the University of Saskatchewan explained to NPR last year: "Every time the virus replicates it's basically buying a couple evolutionary lottery tickets. Most of those are losers. But sometimes it hits a winner. So the key that people should think about, if they want to slow that process, is: Don't give the virus more opportunities to replicate."
Current Covid Landscape and Mortality Data
This winter season saw other respiratory illnesses—including influenza and RSV—outpacing Covid during its typical surge. However, summer months may bring another increase in cases, a pattern observed since the pandemic's onset.
While Covid deaths, positive tests, and emergency room visits have declined since last year, thousands of fatalities continue. CDC data indicates more than 3,600 Covid deaths have occurred so far this year, underscoring the virus's ongoing public health impact despite its transition to endemic status.
